Exact Mass: 282.97
Exact Mass Matches: 282.97
Found 121 metabolites which its exact mass value is equals to given mass value 282.97,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Procymidone
CONFIDENCE standard compound; EAWAG_UCHEM_ID 3102 CONFIDENCE standard compound; INTERNAL_ID 8485 D016573 - Agrochemicals D010575 - Pesticides
Nitrofen
Nitrofen is an herbicide of the diphenyl ether class. Because of concerns about its carcinogenicity, the use of nitrofen is banned in the European Union and in the United States. CONFIDENCE standard compound; EAWAG_UCHEM_ID 3098 CONFIDENCE standard compound; INTERNAL_ID 43 D010575 - Pesticides > D006540 - Herbicides D016573 - Agrochemicals
Risedronate
Risedronate is only found in individuals that have used or taken this drug. It is a bisphosphonate used to strengthen bone, treat or prevent osteoporosis, and treat Pagets disease of bone.The action of risedronate on bone tissue is based partly on its affinity for hydroxyapatite, which is part of the mineral matrix of bone. Risedronate also targets farnesyl pyrophosphate (FPP) synthase. Nitrogen-containing bisphosphonates (such as pamidronate, alendronate, risedronate, ibandronate and zoledronate) appear to act as analogues of isoprenoid diphosphate lipids, thereby inhibiting FPP synthase, an enzyme in the mevalonate pathway. Inhibition of this enzyme in osteoclasts prevents the biosynthesis of isoprenoid lipids (FPP and GGPP) that are essential for the post-translational farnesylation and geranylgeranylation of small GTPase signalling proteins. This activity inhibits osteoclast activity and reduces bone resorption and turnover. In postmenopausal women, it reduces the elevated rate of bone turnover, leading to, on average, a net gain in bone mass. M - Musculo-skeletal system > M05 - Drugs for treatment of bone diseases > M05B - Drugs affecting bone structure and mineralization > M05BA - Bisphosphonates C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators
2,6-Dimethyl-3-(2-propenyl)benzothiazolium bromide
ethyl 5,7-dichloro-2-methylquinoline-3-carboxylate
2-Chloro-4-(morpholin-4-yl)thieno[2,3-d]pyrimidine-6-carboxaldehyde
ethyl 4,6-dichloro-8-methylquinoline-3-carboxylate
3-AMINO-4(PHENYLSULFONYL)THIOPHENE-2-CARBOXYLIC ACID
METHYL 2-[[5-(TRIFLUOROMETHYL)-2-PYRIDYL]SULFONYL]ACETATE
2-(3-chlorobenzoyl)-3,3-bis(methylsulfanyl)prop-2-enenitrile
2-(bromomethyl)-1-nitro-4-(trifluoromethyl)benzene
2-BROMO-6-METHYL-5H-PYRROLO[2,3-B]PYRAZINE-7-CARBOXYLIC ACID ETHYL ESTER
3-Pyridinecarboxylic acid, 2-bromo-5-(trifluoromethyl)-, methyl ester
2-[[4-(TRIFLUOROMETHYL)PHENYL]SULPHONYL]ETHANETHIOAMIDE
2-(4-CHLOROBENZOYL)-3,3-DI(METHYLTHIO)ACRYLONITRILE
(s)-3-amino-4-(3,4-dichlorophenyl)butanoic acid hydrochloride
6,8-dichloro-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-4-carboxylic acid
2H-INDOL-2-ONE, 1,3-DIHYDRO-5-BROMO-3-HYDROXY-3-(2-OXOPROPYL)-
(r)-3-amino-4-(2,4-dichlorophenyl)butanoic acid hydrochloride
2-AMINO-2-(4-BROMO-2-FLUOROPHENYL)ACETIC ACID HYDROCHLORIDE
5-[(4-bromophenyl)methylidene]-1,3-thiazolidine-2,4-dione
2-(4-chlorophenyl)sulfanylpyridine-3-carbonyl chloride
2-(BROMOMETHYL)-1-NITRO-3-(TRIFLUOROMETHYL)BENZENE
ETHYL 2-(4-CHLOROPHENYL)-4-HYDROXYTHIAZOLE-5-CARBOXYLATE
5-OXO-6-TRIFLUOROMETHANESULFONYLOXY-1,2,3,5-TETRAHYDROINDOLIZINE
4-(4-BROMOPHENYL)-5-METHYL-2(3H)-THIAZOLONE HYDRAZONE
6-AMINO-5-CHLORO-2-(4-CHLORO-PHENYL)-PYRIMIDINE-4-CARBOXYLIC ACID
2-Chloro-4-morpholinothieno[3,2-d]pyrimidine-6-carbaldehyde
(([3-(TRIFLUOROMETHYL)PHENYL]SULFONYL)AMINO)ACETIC ACID
4,7-DICHLORO-8-METHYLQUINOLINE-3-CARBOXYLICETHYLESTER
(5-CYCLOPROPYL-3-(2,6-DICHLOROPHENYL)ISOXAZOL-4-YL)METHANOL
4,7-Dichloro-8-fluoro-2-(trifluoromethyl)quinoline
1-(Bromomethyl)-4-nitro-2-(trifluoromethyl)benzene
2-(2-CHLOROBENZOYL)-3,3-DI(METHYLTHIO)ACRYLONITRILE
(s)-3-amino-4-(2,4-dichlorophenyl)butanoic acid hydrochloride
(S)-3-Amino-4-(2,4-dichlorophenyl)-butyric acid-HCl
methyl 3-(4-bromophenyl)-4,5-dihydroisoxazole-5-carboxylate
N-(6-chloropyridazin-3-yl)-4-methylbenzenesulfonamide
3-Bromo-1-isopropyl-5-(trifluoromethyl)pyridin-2(1H)-one
3-PYRROLIDINECARBOXYLIC ACID, 1-(4-BROMOPHENYL)-2-OXO-
2-bromo-4,6-dihydro-4-Methyl-5H-Thieno[2,3:4,5]pyrrolo[2,3-d]pyridazin-5-one
(r)-3-amino-4-(3,4-dichlorophenyl)butanoic acid hydrochloride
1-(4-BROMO-PHENYL)-3,3-BIS-METHYLSULFANYL-PROPENONE
4-(Methylsulfonamido)-2-(trifluoromethyl)benzoic Acid
5-amino-4-chloro-2-(2-oxidomuconoyl)pyridazin-3(2H)-one(2-)
Risedronic acid
M - Musculo-skeletal system > M05 - Drugs for treatment of bone diseases > M05B - Drugs affecting bone structure and mineralization > M05BA - Bisphosphonates C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators
NS3861
NS3861 is an agonist of nicotinic acetylcholine receptors (nAChRs) and binds with high affinity to heteromeric α3β4 nAChR. The binding Ki values of 0.62, 25, 7.8, 55 nM for α3β4, α3β2, α4β4, α4β2, respectively[1].
